OR WAIT null SECS
© 2021 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
KAISER FOUNDATION HEALTH PLAN OF CO
10400 E ALAMEDA AVE
Valerie DeBenedette is managing editor of Drug Topics.
August 01, 2012
A new study seems to indicate that adding cetuximab to the standard therapy for resected stage 3 colon cancer provides no additional benefits.